Concepedia

Jiasheng Fu

JF

Statistics

Publications

10

Citations

684

H-Index

10

Active since

2008

Affiliations

Amgen (United States)(Current)

Jiasheng Fu is an author at Amgen (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2008–2020

10

Publications

10

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

, , +7

Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction

Ana Z. González, John Eksterowicz, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 83 citations · Full text

, , +8

Discovery of AMG 925, a FLT3 and CDK4 Dual Kinase Inhibitor with Preferential Affinity for the Activated State of FLT3

Zhihong Li, Xianghong Wang, John Eksterowicz et al. · Journal of Medicinal Chemistry · 2014 · 72 citations · Full text

, , +16

Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres

Ana Z. González, Zhihong Li, Hilary P. Beck et al. · Journal of Medicinal Chemistry · 2014 · 56 citations · Full text

, , +7

Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Xuelei Yan et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

, , +9

1–5 of 10